Home › Peripheral T-Cell Lymphoma › Ohio › Columbus
Peripheral T-Cell Lymphoma clinical trials in Columbus, OH
3 studies for Peripheral T-Cell Lymphoma are looking for participants at sites in and around Columbus (within about 30 miles). Open a study to see who can join and how to contact the study team.
Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma
RecruitingPhase 3
- The Ohio State University, Columbus
Chemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia/Lymphoma
RecruitingEarly phase 1
- Nationwide Children's Hospital, Columbus
Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma
RecruitingPhase 2
- Ohio State University Comprehensive Cancer Center, Columbus
Peripheral T-Cell Lymphoma trials in other cities
- Houston, TX9 studies
- New York City, NY6 studies
- Baldwin Park, CA5 studies
- Boston, MA5 studies
- Philadelphia, PA4 studies
- Atlanta, GA3 studies
- Aurora, CO3 studies
- Ann Arbor, MI3 studies
Other studies in Columbus
- Non-Small Cell Lung Cancer55 studies
- Cancer (all types)39 studies
- Breast Cancer39 studies
- Ovarian Cancer39 studies
- Lung Cancer36 studies
- Acute Myeloid Leukemia34 studies
- Chronic Lymphocytic Leukemia29 studies
- Metastatic Cancer27 studies
- Endometrial Cancer26 studies
- Colorectal Cancer24 studies
- Multiple Myeloma24 studies
- Prostate Cancer24 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.